Abiomed (ABMD) stock Forecast for 2021 – 2025

Abiomed (ABMD) stock Forecast for 2022 – 2026

Last update: October 2, 2022 (10:35)

Sector: Healthcare

The share price of Abiomed, Inc. (ABMD) now

What analysts predict: $330

52-week high/low: $379.3 / $219.85

50/200 Day Moving Average: $273.47 / $286.84

This figure corresponds to the average price over the previous 50/200 days. For Abiomed stocks, the 50-day moving average is the resistance level today.

For Abiomed stocks, the 200-day moving average is the resistance level today.

Are you interested in Abiomed, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Abiomed stock price in 2022, 2023, 2024, 2025, 2026. How much will one Abiomed share be worth in 2022 - 2026?

When should I take profit in Abiomed stock? When should I record a loss on Abiomed stock? What are analysts' forecasts for Abiomed stock? What is the future of Abiomed stock?

We forecast Abiomed stock performance using neural networks based on historical data on Abiomed stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Abiomed stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Abiomed shares. This happens once a day.



Fresh insight into Abiomed stock

View all analytics

Abiomed: Correction Offers Good Buying Opportunity

Abiomed: Correction Offers Good Buying Opportunity
September 28, 2022

Summary Abiomed’s Impella range of micro heart pumps enjoy rising demand in the marketplace. The company’s OXY-1 System cardiopulmonary support device has strong growth prospect. The company’s revenue will grow … Read more

Abiomed: Small Premium For Access To ~11% Normalized ROIC

Abiomed: Small Premium For Access To ~11% Normalized ROIC
August 4, 2022

Summary Abiomed came in with another set of robust earnings yesterday, with double-digit growth from top to bottom. Earnings remain steady, however, the company exhibits the profitability features investors are … Read more



Historical and forecast chart of Abiomed stock

The chart below shows the historical price of Abiomed stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Abiomed stock price can be found in the table below.

Long-term forecasts by years.

Abiomed daily forecast for a month

Date Target Pes. Opt. Vol., %
Oct 04 250.27 247.26 251.83 1.85
Oct 05 251.89 248.75 253.53 1.92
Oct 06 248.37 243.96 250.79 2.80
Oct 07 250.17 248.54 252.30 1.51
Oct 08 249.92 245.17 252.36 2.93
Oct 09 248.67 244.57 251.16 2.69
Oct 10 248.11 244.26 251.64 3.02
Oct 11 245.63 241.15 250.42 3.85
Oct 12 242.56 239.89 244.68 2.00
Oct 13 243.16 241.34 245.60 1.76
Oct 14 237.88 233.36 241.98 3.70
Oct 15 243.76 239.25 245.29 2.52
Oct 16 247.30 244.64 250.57 2.43
Oct 17 247.54 244.45 250.76 2.58
Oct 18 250.33 249.08 254.77 2.29
Oct 19 253.52 249.34 258.34 3.61
Oct 20 254.54 250.91 257.27 2.54
Oct 21 251.74 248.34 255.51 2.89
Oct 22 249.03 245.73 252.33 2.69
Oct 23 250.65 249.27 252.53 1.31
Oct 24 248.89 245.91 250.45 1.85
Oct 25 245.91 242.16 250.82 3.58
Oct 26 244.55 241.19 248.28 2.94
Oct 27 245.65 240.80 248.17 3.06
Oct 28 244.43 242.96 249.13 2.54
Oct 29 247.73 245.19 250.76 2.27
Oct 30 248.84 247.10 251.95 1.96
Oct 31 247.29 243.51 251.06 3.10
Nov 01 245.00 242.36 248.06 2.35
Nov 02 238.87 234.28 240.55 2.68

Abiomed Daily Price Targets


Abiomed Stock Forecast 10-04-2022.

Forecast target price for 10-04-2022: $250.27. Positive dynamics for Abiomed shares will prevail with possible volatility of 1.814%.

Pessimistic target level: 247.26

Optimistic target level: 251.83


Abiomed Stock Forecast 10-05-2022.

Forecast target price for 10-05-2022: $251.89. Positive dynamics for Abiomed shares will prevail with possible volatility of 1.888%.

Pessimistic target level: 248.75

Optimistic target level: 253.53


Abiomed Stock Forecast 10-06-2022.

Forecast target price for 10-06-2022: $248.37. Negative dynamics for Abiomed shares will prevail with possible volatility of 2.723%.

Pessimistic target level: 243.96

Optimistic target level: 250.79


Abiomed Stock Forecast 10-07-2022.

Forecast target price for 10-07-2022: $250.17. Positive dynamics for Abiomed shares will prevail with possible volatility of 1.488%.

Pessimistic target level: 248.54

Optimistic target level: 252.30


Abiomed Stock Forecast 10-08-2022.

Forecast target price for 10-08-2022: $249.92. Negative dynamics for Abiomed shares will prevail with possible volatility of 2.847%.

Pessimistic target level: 245.17

Optimistic target level: 252.36


Abiomed Stock Forecast 10-09-2022.

Forecast target price for 10-09-2022: $248.67. Negative dynamics for Abiomed shares will prevail with possible volatility of 2.624%.

Pessimistic target level: 244.57

Optimistic target level: 251.16


ABMD (ABMD) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Oct. 265.35 258.36 274.60 5.91
Nov. 275.28 261.47 282.53 7.45
Dec. 278.32 263.65 290.62 9.28

Abiomed forecast for this year


Abiomed Stock Prediction for Oct 2022

An uptrend is forecast for this month with an optimal target price of $265.353. Pessimistic: $258.36. Optimistic: $274.60


Abiomed Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $275.277. Pessimistic: $261.47. Optimistic: $282.53


Abiomed Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $278.319. Pessimistic: $263.65. Optimistic: $290.62




Abiomed (ABMD) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 267.20 252.44 275.60 8.41
Mar 249.94 235.49 257.38 8.50
Mar 260.35 248.40 266.55 6.81
Apr 276.50 258.17 290.37 11.09
May 264.99 248.32 282.33 12.05
Jun 261.38 254.94 266.94 4.49
Jul 255.39 250.18 266.02 5.96
Aug 247.79 236.62 253.90 6.80
Sep 240.42 230.40 245.12 6.00
Oct 248.39 233.18 260.42 10.46
Nov 249.02 233.14 255.79 8.85
Dec 259.18 244.64 271.08 9.75

Abiomed (ABMD) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 248.60 244.38 262.34 6.85
Feb 264.88 259.92 281.31 7.60
Mar 279.96 264.97 292.81 9.51
Apr 291.86 280.70 307.74 8.79
May 297.32 280.13 311.47 10.06
Jun 309.19 288.17 329.17 12.46
Jul 318.66 305.38 324.07 5.77
Aug 306.74 291.09 322.38 9.70
Sep 293.70 278.22 307.68 9.57
Oct 285.21 271.88 293.21 7.28
Nov 305.09 294.72 314.69 6.35
Dec 310.02 293.15 325.83 10.03



Abiomed (ABMD) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 305.54 286.58 315.41 9.14
Mar 307.10 297.96 326.68 8.79
Mar 307.62 287.49 317.03 9.32
Apr 288.53 277.50 307.42 9.73
May 291.48 286.03 307.58 7.01
Jun 289.99 284.07 299.60 5.18
Jul 311.93 299.20 329.16 9.10
Aug 314.31 305.23 332.21 8.12
Sep 311.91 296.53 321.72 7.83
Oct 312.17 304.21 319.87 4.89
Nov 305.54 292.29 323.46 9.63
Dec 321.90 310.96 339.69 8.46

Abiomed (ABMD) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 295.63 285.83 313.48 8.82
Mar 275.03 268.48 285.08 5.82
Mar 265.21 249.66 270.85 7.82
Apr 260.03 247.65 265.55 6.74
May 281.91 277.11 289.81 4.38
Jun 289.10 283.20 308.75 8.28
Jul 305.80 294.63 319.58 7.81
Aug 319.32 305.48 336.15 9.12
Sep 322.31 310.53 332.17 6.52
Oct 310.25 290.21 328.19 11.57
Nov 321.59 314.21 340.73 7.78
Dec 311.75 299.56 324.74 7.75

Abiomed information and performance

Abiomed is a manufacturer of medical implants, including the AbioCor artificial heart and impella. The company is headquartered in Danvers, Massachusetts and has three subsidiary offices: two in Germany in Berlin and Aachen and one in Japan. Michael R. Minogue joined Abiomed in 2004 and serves as CEO, Chairman and President.

Abiomed Address

22 CHERRY HILL DR, DANVERS, MA, US

Market Capitalization: 11 167 697 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 279 261 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 52.27

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.75

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 4.7

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.056

Quarterly Revenue Growth YOY: 0.097

Trailing PE: 52.27

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 9.77

Enterprise Value (EV) /Revenue

EV To EBITDA: 36.28

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 45460900

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.